LivaNova USA, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$164.8M
Doctors Paid
12,749
Transactions
71,251
2024 Total
$26.3M
Payment Breakdown by Category
Royalty/License$100.2M (60.8%)
Research$50.1M (30.4%)
Travel$2.6M (1.6%)
Food & Beverage$2.2M (1.3%)
Consulting$1.4M (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $100.2M | 38 | 60.8% |
| Unspecified | $50.1M | 12,070 | 30.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4.8M | 2,302 | 2.9% |
| Travel and Lodging | $2.6M | 7,674 | 1.6% |
| Food and Beverage | $2.2M | 47,410 | 1.3% |
| Consulting Fee | $1.4M | 765 | 0.8% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $851,786 | 497 | 0.5% |
| Gift | $665,945 | 60 | 0.4% |
| Education | $649,144 | 143 | 0.4% |
| Debt forgiveness | $515,615 | 82 | 0.3% |
| Honoraria | $260,223 | 64 | 0.2% |
| Grant | $166,850 | 19 | 0.1% |
| Compensation for serving as faculty or as a speaker for a medical education program | $164,659 | 100 | 0.1% |
| Long term medical supply or device loan | $115,698 | 8 | 0.1% |
| Space rental or facility fees (teaching hospital only) | $81,875 | 18 | 0.0% |
| Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program | $500.00 | 1 | 0.0% |
Payments by Type
General
$114.7M
59,181 transactions
Research
$50.1M
12,070 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| ANTHEM HFrEF | $8.1M | 1 | 1,679 |
| (OSPREY)Treating Obstructive Sleep APnea using TaRgetEd HYpoglossal Neurostimulation | $7.7M | 0 | 312 |
| A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression | $7.5M | 2 | 1,801 |
| A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression (RECOVER) | $5.9M | 1 | 1,299 |
| RECOVER: A PRospective, Multi-cEnter, Randomized Controlled Blinded Trial DemOnstrating the Safety and Effectiveness of VNS Therapy System as AdjunctivE Therapy Versus a No-Stimulation Control in Subjects With Treatment-Resistant Depression | $3.1M | 0 | 604 |
| THN3 | $2.0M | 1 | 355 |
| The RECOVERsUb-study, Which Leverages quaNtitative and Credible Research tOols From Verily, Will providE Assessment measuRes for Depressive Episodes | $1.8M | 0 | 485 |
| RECOVER | $1.4M | 0 | 2,016 |
| Microburst VNS Therapy Feasibility Study in Subjects with Refractory Epilepsy | $928,956 | 2 | 135 |
| Comprehensive Outcomes Registry in Subjects with Epilepsy Treated with Vagus Nerve Stimulation Therapy | $902,025 | 0 | 395 |
| ANTHEM-HFrEF | $890,088 | 0 | 74 |
| Microburst Study | $874,635 | 0 | 78 |
| TandemHeart Experiences and Methods THEME Registry | $605,667 | 0 | 31 |
| Mitroflow DL PAS TMT001 | $488,991 | 1 | 90 |
| RECOVER: A Prospective, Multi-Center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No-Stimulation Control in Subjects with Treatment Resistant Depression | $466,299 | 0 | 5 |
| Believe APR002 Study | $445,849 | 0 | 51 |
| Theme | $436,186 | 0 | 19 |
| (THN3)Targeted Hypoglossal Neurostimulation Study #3 | $430,123 | 0 | 71 |
| Comprehensive Outcomes Registry in Subjects with Epilepsy Treated with Vagus Nerve Stimulation Therapy (CORE-VNS) | $363,357 | 0 | 108 |
| PERSIST-AVR TPS003 -US- | $337,449 | 0 | 39 |
| LivaNova UNCOVER | $298,929 | 0 | 829 |
| Believe APR002 Clinical Study | $280,945 | 3 | 38 |
| Core-VNS LNN-801 | $272,801 | 0 | 53 |
| The RECOVER sUb-study, which leverages quaNtitative and Credible research tOols from Verily, will providE assessment measuRes for depressive episodes (UNCOVER) | $271,581 | 0 | 511 |
| THEME | $260,183 | 0 | 35 |
| Patterns Of Care In Childhood Epilepsy: Use Of Vagus Nerve Stimulation in US Hospitals | $250,737 | 0 | 6 |
| The TMVR System, PRELUDE Study | $246,252 | 0 | 73 |
| E41 Microburst Study | $239,839 | 2 | 22 |
| Identifying MEG-derived functional connectivity signatures as potential biomarkers for response to VNS therapy in children with refractory epilepsy | $237,763 | 0 | 5 |
| Mitroflow PAS Study | $197,773 | 0 | 58 |
Payments by Medical Specialty
Top Paid Doctors — Page 2
| Doctor | Specialty | Location | Total | 2020 |
|---|---|---|---|---|
| Mahesh Ramchandani, Md, MD | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Houston, TX | $84,804 | $0 |
| Reed Quinn, Md, MD | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Greeley, CO | $84,331 | $0 |
| Dr. Sreekumar Subramanian, Md, MD | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Nashville, TN | $83,833 | $0 |
| Dr. Narendra Sastry, M.d, M.D | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Tampa, FL | $82,764 | $0 |
| Dr. Muhammad Zafar, M.d, M.D | Pediatrics | Durham, NC | $82,169 | $0 |
| Ofer Jacobowitz, M. D.,Phd, M. D.,PHD | Otolaryngic Allergy | New York, NY | $78,814 | $0 |
| Dr. Charles Conway, Md, MD | Psychiatry | Saint Louis, MO | $77,420 | $0 |
| Karl Kern, Md, MD | Cardiovascular Disease | Tucson, AZ | $76,875 | $0 |
| Mrs. Karen Keough, Md, MD | Neurology with Special Qualifications in Child Neurology | Austin, TX | $70,121 | $0 |
| Dr. Hal Corwin, Md, MD | Neurology | Louisville, KY | $68,877 | $0 |
| Dr. Alberto Maldonado-Molina, Md, MD | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Ponce, PR | $65,939 | $0 |
| Dr. Peter Carson, M.d, M.D | Specialist | Washington, DC | $63,635 | $0 |
| James Valeriano, Md, MD | Neurology | Pittsburgh, PA | $62,619 | $0 |
| Dr. David Opperman, M.d, M.D | Otolaryngology | Denver, CO | $59,403 | $0 |
| Sandi Lam, M.d, M.D | Neurological Surgery | Chicago, IL | $56,766 | $0 |
| Jerzy Szaflarski | Neurology | Birmingham, AL | $55,259 | $0 |
| Ron Oren, Md, MD | Cardiovascular Disease | Naperville, IL | $49,801 | $0 |
| Dr. Gustavo Alva, M.d, M.D | Psychiatry | Orange, CA | $49,761 | $0 |
| Dr. David Robaczewski, Md, MD | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Roanoke, VA | $49,240 | $0 |
| Ayan Patel, M.d, M.D | Cardiovascular Disease | Boston, MA | $46,411 | $0 |
| Rajan Patel, M.d, M.D | Cardiovascular Disease | New Orleans, LA | $44,413 | $0 |
| Richard Patten, M.d, M.D | Cardiovascular Disease | Burlington, MA | $43,516 | $0 |
| Raman Sankar, M.d, M.D | Neurodevelopmental Disabilities | Los Angeles, CA | $43,319 | $0 |
| Eugene Chung, M.d, M.D | Cardiovascular Disease | Cincinnati, OH | $42,701 | $0 |
| Ronald Davis, Md, MD | Neurology with Special Qualifications in Child Neurology | Winter Park, FL | $42,379 | $0 |
Ad
Top Products
- VNS Therapy $65.5M
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR $35.1M
Associated Products (54)
- VNS Therapy $70.9M
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR $35.1M
- VNS Therapy SenTiva Model 1000 Generator $14.8M
- VNS - Sentiva $14.4M
- VNS THERAPY SYMMETRY MODEL 8103 GENERATOR $7.0M
- VNS Therapy Symmetry Model 8103 Generator $6.5M
- VNS - Vitaria $5.3M
- VNS - Symmetry $4.1M
- THN Sleep Therapy $2.9M
- Perceval $2.0M
- Aortic Tissue Valve - Perceval $1.1M
- TandemHeart $1.1M
- TMVR $812,043
- Aortic Tissue Valve - Mitroflow PRT $675,400
- Heart Lung Equipment $387,658
- XTRA Autotransfusion System $370,557
- Crown PRT $341,690
- Tandem Heart Kit $323,619
- Aortic Tissue Valve - Crown PRT $323,330
- TandemLife $287,102
- TANDEMHEART $260,779
- LIFESPARC $250,626
- Paradym RF CRT-D $242,134
- Autotransfusion - Xtra $215,461
- LifeSPARC $125,557
- VNS Therapy Demipulse Duo Model 104 Generator $123,623
- VNS Therapy PerenniaFLEX Model 304 Lead $113,260
- Heart Lung Equipment - S5 $93,153
- Platinium $86,135
- ProtekDuo Kit $75,819
- S5 CONSOLE $72,190
- Aortic Tissue Valve - Solo Smart $69,831
- VNS Therapy Demipulse Model 103 Generator $62,594
- Heart Lung Equipment - CP5 $57,589
- REPLY DR $50,704
- LifeSPARC System $46,442
- PROTEKDUO $44,554
- Memo4D $40,782
- S5 Console $39,672
- Memo3D ReChord $38,207
- Tandem Life Kit $31,512
- Perfusion Tubing $29,348
- MICS Instruments $27,617
- Hemolung Cartridge Kit $26,471
- CONNECT $20,687
- ESSENZ $13,943
- Perceval S $12,746
- HEART LUNG EQUIPMENT $12,688
- ProtekDuo $12,420
- Mitral Ring - Memo 3D ReChord $11,922
- Heart Lung Equipment - Electrical Remote-Controlled Tubing Clamp (ERC) $11,266
- MICS Cannulae $10,997
- Heart Lung Equipment - SCP $10,781
- Heart Lung Equipment - SCPC $10,330
Payment Categories
- Food & Beverage $2.2M
- Consulting $1.4M
- Travel & Lodging $2.6M
- Research $50.1M
- Royalties $100.2M
About LivaNova USA, Inc.
LivaNova USA, Inc. has made $164.8M in payments to 12,749 healthcare providers, recorded across 71,251 transactions in the CMS Open Payments database. In 2024, the company paid $26.3M. The top product by payment volume is VNS Therapy ($65.5M).
Payments were distributed across 184 medical specialties. The top specialty by payment amount is Neurology ($102.8M to 3,310 doctors).
Payment categories include: Food & Beverage ($2.2M), Consulting ($1.4M), Research ($50.1M), Travel & Lodging ($2.6M), Royalties ($100.2M).
LivaNova USA, Inc. is associated with 54 products in the CMS Open Payments database, including VNS Therapy, VNS THERAPY SENTIVA MODEL 1000 GENERATOR, and VNS Therapy SenTiva Model 1000 Generator.